Drug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a single shot, has passed a vital part of final-stage scientific checks.
The phase-three trial shows the vaccine arms the body with protective antibodies.
And it does so as effectively as separate flu and Covid shots, results suggest.
Fewer injections would be more convenient and simpler, Moderna says.
Chief executive Stephane Bancel told BBC News he hoped the messenger ribonucleic acid (mRNA) vaccine could be made widely available in 2026 - or perhaps, 2025.
RuBisCO@slrpnk.netEnglish7·3 months ago